definiens: ) . Syndax shall, within thetime defined in the Clinical Quality Agreements, perform ( i ) with respect to the Alliance Compound, the acceptanceprocedures allocated to it under the Clinical Quality Agreements, and ( ii ) with respect to the Syndax Compound, thetesting and release procedures allocated to it under the Clinical Quality Agreements . Syndax shall take all stepsnecessary in its reasonable discretion to determine that the Alliance Compound or Syndax Compound, as applicable, is suitable for release before making such Alliance Compound or Syndax Compound, as applicable, available forhuman use, and the Alliance shall provide cooperation or assistance as reasonably requested by Syndax in * * * INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WASREQUESTED . ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933,AS AMENDED